Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?

Detalles Bibliográficos
Autores principales: Honore, Patrick M., Jacobs, Rita, Hendrickx, Inne, De Waele, Elisabeth, Van Gorp, Viola, Spapen, Herbert D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729072/
https://www.ncbi.nlm.nih.gov/pubmed/26812984
http://dx.doi.org/10.1186/s13054-016-1196-6
_version_ 1782412217067503616
author Honore, Patrick M.
Jacobs, Rita
Hendrickx, Inne
De Waele, Elisabeth
Van Gorp, Viola
Spapen, Herbert D.
author_facet Honore, Patrick M.
Jacobs, Rita
Hendrickx, Inne
De Waele, Elisabeth
Van Gorp, Viola
Spapen, Herbert D.
author_sort Honore, Patrick M.
collection PubMed
description
format Online
Article
Text
id pubmed-4729072
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47290722016-01-28 Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II? Honore, Patrick M. Jacobs, Rita Hendrickx, Inne De Waele, Elisabeth Van Gorp, Viola Spapen, Herbert D. Crit Care Letter BioMed Central 2016-01-27 /pmc/articles/PMC4729072/ /pubmed/26812984 http://dx.doi.org/10.1186/s13054-016-1196-6 Text en © Honore et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter
Honore, Patrick M.
Jacobs, Rita
Hendrickx, Inne
De Waele, Elisabeth
Van Gorp, Viola
Spapen, Herbert D.
Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?
title Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?
title_full Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?
title_fullStr Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?
title_full_unstemmed Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?
title_short Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?
title_sort fondaparinux: another potential treatment for heparin-induced thrombocytopenia type ii?
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729072/
https://www.ncbi.nlm.nih.gov/pubmed/26812984
http://dx.doi.org/10.1186/s13054-016-1196-6
work_keys_str_mv AT honorepatrickm fondaparinuxanotherpotentialtreatmentforheparininducedthrombocytopeniatypeii
AT jacobsrita fondaparinuxanotherpotentialtreatmentforheparininducedthrombocytopeniatypeii
AT hendrickxinne fondaparinuxanotherpotentialtreatmentforheparininducedthrombocytopeniatypeii
AT dewaeleelisabeth fondaparinuxanotherpotentialtreatmentforheparininducedthrombocytopeniatypeii
AT vangorpviola fondaparinuxanotherpotentialtreatmentforheparininducedthrombocytopeniatypeii
AT spapenherbertd fondaparinuxanotherpotentialtreatmentforheparininducedthrombocytopeniatypeii

Ejemplares similares